2-(9-Oxo-9H-xanthen-2-yl)propanoic acid, 98%, 1g

4'-chloro-3-(3-pyrrolinomethyl) benzophenone, 97.0%, 1g

2-(1H-indol-3-yl)-2-(3-methoxyphenyl)ethanamine, 1g

(R)-(+)-DBD-Pro-COCl [=(R)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]>95.0%(HPLC)100mg

Methyl 4-[6-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)pyridin-3-yl]benzoate, 95.0%, 1g

3-Bromo-4-oxo-piperidine-1-carboxylic acid benzyl ester, 95.0%, 1g

2-chloro-5-(2-methoxyphenyl)pyrazine, 95.0%, 1g

2-Bromo-5-chloroisonicotinic acid, 95.0%, 5g

Ethyl 1-phenyl-1H-pyrazole-4-carboxylate, 97.0%, 10g

2-bromopyrazino[2,3-b]pyrazine, 95.0%, 5g

Ethyl Methyl Carbonate>98.0%(GC)25mL

Cyclohexylhydrazine Hydrochloride>98.0%(T)25g

2-Bromo-5-fluoropyridine-3-carbonitrile, 98%, 100mg